Skip to content

Low Dose Bupivacaine Spinal for Trans Uretral Prostatectomy.

Low Dose, Low Concentration Different Baricity Bupivacaine for Transuretral Prostatectomy.

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01861041
Acronym
TURP
Enrollment
52
Registered
2013-05-23
Start date
2013-05-31
Completion date
2013-07-31
Last updated
2013-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostate Hyperplasia

Keywords

low dose, different baricity, spinal anesthesia

Brief summary

Spinal anesthesia, is used during the transuretheral resection of the prostate.Low dose hyperbaric local anesthetics have been used to enhance the resolution of the spinal block. We compared the efficacy and duration of the spinal block with two different bupivacaine baricities. * Group I: low dose isobaric group * GroupII: Low dose hyperbaric group

Detailed description

Patients undergoing TURP were randomly allocated into two groups. * Group I: Received fentanyl 20 µgr (0.4ml),heavy bupivacaine 0.5% (1.5 ml)and normal saline % 0.9 NaCl ( 1.1ml) * Group II: Received fentanyl 20 µgr (0.4 ml), plain bupivacaine 0.5%(1.5 ml) normal saline 0.9% NaCl (1.1 mL) in total bupivacaine 0.25% (3ml) intrathecally. Onset and duration of the sensory block, the degree of the motor block, side - effects and perioperative analgesic requirement assesed.

Interventions

DRUGHeavy Bupivacaine

7,5 mg intrathecal hyperbaric bupivacain,

7.5 mg intratecal isobaric bupivacain

Sponsors

Diskapi Yildirim Beyazit Education and Research Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
50 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* 50-85 years ASA 1-4 BENİGN PROSTAT HYPERPLASİ

Exclusion criteria

* Allergy of study drugs * Morbid obesity * Spinal anesthesia contrindications * Bleeding dyscrasias

Design outcomes

Primary

MeasureTime frameDescription
Spinal Block Quality15 minute after intrathecal injectionSensory block assesment with pinpric test.

Secondary

MeasureTime frameDescription
Spinal block regression5 minute after arrival at PACUSensory block assesment with pinprick test

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026